Static Chart Achilles Therapeutics plc

Equities

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-07 EDT			5-day change	1st Jan Change
0.826 ^USD	-0.46%		+10.13%	-7.09%

04-05	Piper Sandler Downgrades Achilles Therapeutics to Neutral From Overweight, Cuts Price Target to $2 From $8	MT
04-05	Chardan Capital Adjusts Achilles Therapeutics Price Target to $6 From $11, Maintains Buy Rating	MT

Duration

Period